The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with
MEDLINE®/PubMed®, was founded by the renowned Dr. Perry Robins, MD. Now in it's eighth year,
it offers one of the fastest routes to disseminate dermatologic information, and is considered the
fastest growing publication in dermatology.
We present original articles, award-winning case reports, and timely features pertaining to new methods,
techniques, and drug therapy in dermatology, which provides readers with peer-reviewed content of the
utmost quality.
Our high standards of content are maintained through a balanced, peer-review process. Articles are
reviewed by an International Editorial Board of over 150 renowned experts.
JDD reaches around 14,500 dermatology healthcare professionals and has been recognized as the official
publication of the International Society of Dermatologic Surgery (ISDS) and the Orlando Dermatology
Aesthetic and Clinical (ODAC) Conference.
The extremely current and practical editorial content of JDD results in high readership and maximum
exposure among the dermatology community.
Our Mission is Excellence Through Peer Review: To educate physicians, optimize patient outcomes,
and disseminate key scientific information.